Logo image of EGBN

EAGLE BANCORP INC (EGBN) Stock Fundamental Analysis

NASDAQ:EGBN - Nasdaq - US2689481065 - Common Stock - Currency: USD

22.77  -1.09 (-4.57%)

After market: 22.77 0 (0%)

Fundamental Rating

3

EGBN gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 405 industry peers in the Banks industry. EGBN has a bad profitability rating. Also its financial health evaluation is rather negative. EGBN is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year EGBN was profitable.
EGBN had a positive operating cash flow in the past year.
Of the past 5 years EGBN 4 years were profitable.
EGBN had a positive operating cash flow in 4 of the past 5 years.
EGBN Yearly Net Income VS EBIT VS OCF VS FCFEGBN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

1.2 Ratios

With a Return On Assets value of -0.37%, EGBN is not doing good in the industry: 95.24% of the companies in the same industry are doing better.
With a Return On Equity value of -3.44%, EGBN is not doing good in the industry: 94.99% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -0.37%
ROE -3.44%
ROIC N/A
ROA(3y)0.57%
ROA(5y)0.88%
ROE(3y)5.18%
ROE(5y)7.85%
ROIC(3y)N/A
ROIC(5y)N/A
EGBN Yearly ROA, ROE, ROICEGBN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10

1.3 Margins

EGBN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
EGBN Yearly Profit, Operating, Gross MarginsEGBN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1

2. Health

2.1 Basic Checks

EGBN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EGBN has been increased compared to 1 year ago.
EGBN has less shares outstanding than it did 5 years ago.
EGBN has a better debt/assets ratio than last year.
EGBN Yearly Shares OutstandingEGBN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EGBN Yearly Total Debt VS Total AssetsEGBN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

The Debt to FCF ratio of EGBN is 6.50, which is on the high side as it means it would take EGBN, 6.50 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EGBN (6.50) is worse than 67.92% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that EGBN is somewhat dependend on debt financing.
EGBN has a worse Debt to Equity ratio (0.90) than 85.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.5
Altman-Z N/A
ROIC/WACCN/A
WACC14.78%
EGBN Yearly LT Debt VS Equity VS FCFEGBN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
EGBN Yearly Current Assets VS Current LiabilitesEGBN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

3

3. Growth

3.1 Past

EGBN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -43.03%.
Measured over the past years, EGBN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.37% on average per year.
Looking at the last year, EGBN shows a decrease in Revenue. The Revenue has decreased by -1.11% in the last year.
EGBN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.47% yearly.
EPS 1Y (TTM)-43.03%
EPS 3Y-30.16%
EPS 5Y-15.37%
EPS Q2Q%-25.37%
Revenue 1Y (TTM)-1.11%
Revenue growth 3Y-5.43%
Revenue growth 5Y-2.47%
Sales Q2Q%-3.01%

3.2 Future

EGBN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.23% yearly.
The Revenue is expected to grow by 6.57% on average over the next years.
EPS Next Y29.31%
EPS Next 2Y26.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year4.73%
Revenue Next 2Y6.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
EGBN Yearly Revenue VS EstimatesEGBN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 100M 200M 300M
EGBN Yearly EPS VS EstimatesEGBN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

6

4. Valuation

4.1 Price/Earnings Ratio

EGBN is valuated correctly with a Price/Earnings ratio of 12.11.
EGBN's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 29.62, EGBN is valued rather cheaply.
EGBN is valuated reasonably with a Price/Forward Earnings ratio of 9.37.
79.70% of the companies in the same industry are more expensive than EGBN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.70. EGBN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 12.11
Fwd PE 9.37
EGBN Price Earnings VS Forward Price EarningsEGBN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of EGBN indicates a rather cheap valuation: EGBN is cheaper than 93.73% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 4.04
EV/EBITDA N/A
EGBN Per share dataEGBN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

EGBN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EGBN's earnings are expected to grow with 26.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y26.23%
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.77%, EGBN has a reasonable but not impressive dividend return.
The stock price of EGBN dropped by -22.58% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
Compared to an average industry Dividend Yield of 3.19, EGBN has a dividend in line with its industry peers.
EGBN's Dividend Yield is a higher than the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 2.77%

5.2 History

EGBN has been paying a dividend for at least 10 years, so it has a reliable track record.
As EGBN did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)N/A
Div Incr Years5
Div Non Decr Years5
EGBN Yearly Dividends per shareEGBN Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of EGBN are negative and hence is the payout ratio. EGBN will probably not be able to sustain this dividend level.
DP-130.23%
EPS Next 2Y26.23%
EPS Next 3YN/A
EGBN Yearly Income VS Free CF VS DividendEGBN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

EAGLE BANCORP INC

NASDAQ:EGBN (2/21/2025, 8:15:21 PM)

After market: 22.77 0 (0%)

22.77

-1.09 (-4.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-22 2025-01-22/amc
Earnings (Next)04-22 2025-04-22/amc
Inst Owners79.23%
Inst Owner Change-90.93%
Ins Owners2.15%
Ins Owner Change2.09%
Market Cap687.65M
Analysts47.5
Price Target29.41 (29.16%)
Short Float %5.36%
Short Ratio6.16
Dividend
Industry RankSector Rank
Dividend Yield 2.77%
Yearly Dividend1.81
Dividend Growth(5Y)N/A
DP-130.23%
Div Incr Years5
Div Non Decr Years5
Ex-Date02-07 2025-02-07 (0.165)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)57.49%
Min EPS beat(2)54.56%
Max EPS beat(2)60.43%
EPS beat(4)2
Avg EPS beat(4)2.48%
Min EPS beat(4)-101.66%
Max EPS beat(4)60.43%
EPS beat(8)5
Avg EPS beat(8)6.15%
EPS beat(12)7
Avg EPS beat(12)4.19%
EPS beat(16)11
Avg EPS beat(16)6.77%
Revenue beat(2)0
Avg Revenue beat(2)-7.54%
Min Revenue beat(2)-8.36%
Max Revenue beat(2)-6.73%
Revenue beat(4)1
Avg Revenue beat(4)-2.99%
Min Revenue beat(4)-8.36%
Max Revenue beat(4)4.18%
Revenue beat(8)3
Avg Revenue beat(8)-2.12%
Revenue beat(12)7
Avg Revenue beat(12)0.16%
Revenue beat(16)11
Avg Revenue beat(16)2.7%
PT rev (1m)-0.57%
PT rev (3m)10.9%
EPS NQ rev (1m)-4.85%
EPS NQ rev (3m)-4.85%
EPS NY rev (1m)-6.17%
EPS NY rev (3m)-6.17%
Revenue NQ rev (1m)-2.29%
Revenue NQ rev (3m)-2.29%
Revenue NY rev (1m)0.68%
Revenue NY rev (3m)-2.55%
Valuation
Industry RankSector Rank
PE 12.11
Fwd PE 9.37
P/S 2.22
P/FCF 4.04
P/OCF 4.04
P/B 0.56
P/tB 0.56
EV/EBITDA N/A
EPS(TTM)1.88
EY8.26%
EPS(NY)2.43
Fwd EY10.68%
FCF(TTM)5.64
FCFY24.77%
OCF(TTM)5.64
OCFY24.77%
SpS10.25
BVpS40.58
TBVpS40.58
PEG (NY)0.41
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.37%
ROE -3.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 55.02%
ROA(3y)0.57%
ROA(5y)0.88%
ROE(3y)5.18%
ROE(5y)7.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 6.5
Debt/EBITDA N/A
Cap/Depr 1.55%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACC14.78%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-43.03%
EPS 3Y-30.16%
EPS 5Y-15.37%
EPS Q2Q%-25.37%
EPS Next Y29.31%
EPS Next 2Y26.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.11%
Revenue growth 3Y-5.43%
Revenue growth 5Y-2.47%
Sales Q2Q%-3.01%
Revenue Next Year4.73%
Revenue Next 2Y6.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-11.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.35%
OCF growth 3YN/A
OCF growth 5YN/A